Home BP-guided antihypertensive therapy in chronic kidney disease: more data are needed

In the era of newly-introduced hypertension guidelines recommending lower blood pressure (BP) targets for drug-treated hypertensives, the necessity for optimized management of hypertension becomes even more urgent. The concept of home BP-guided antihypertensive therapy is for long suggested as a simple and feasible approach to improve BP control rates and optimize the management of hypertension. Home BP-guided antihypertensive therapy is particularly applicable to hypertensives with chronic kidney disease (CKD) for several reasons including the following: (i) difficult-to-control BP and high BP variability in the CKD setting; (ii) poor accuracy of office BP in determining hypertension control status and detecting “white-coat” and “masked” hypertension; (iii) poor value of routine office BP recordings in predicting the longitudinal progression of target-organ damage; (iv) superiority of home BP over office BP recordings in prognosticating the risk of incident end-stage-renal-disease (ESRD) or death.
Source: Journal of the American Society of Hypertension - Category: Cardiology Authors: Tags: Editorial Source Type: research